Switch to Fixed-Ratio Therapy Lowers HbA1c and Hypoglycemia in T2DM Tags Hypoglycemia hBA1c Intermediate acting Long acting Read more about Switch to Fixed-Ratio Therapy Lowers HbA1c and Hypoglycemia in T2DM
Empagliflozin Associated With Lower EAT Thickness in T2DM Tags Echocardiography hBA1c SGLT-2 Inhibitor Read more about Empagliflozin Associated With Lower EAT Thickness in T2DM
Incretin Responses Differ by Glycemic Control in T2DM Tags hBA1c GLP-1 agonists Read more about Incretin Responses Differ by Glycemic Control in T2DM
Downstream Medication Use Differs After GLP-1 vs SGLT2 Start in T2DM Tags GLP-1 agonists SGLT-2 Inhibitor Read more about Downstream Medication Use Differs After GLP-1 vs SGLT2 Start in T2DM
WATCH-DM Score Tracks Mortality Risk in T2DM Without HF Tags Coronary artery disease Read more about WATCH-DM Score Tracks Mortality Risk in T2DM Without HF
Low Melatonin Levels Reported in T2DM Women With Reduced BMD Read more about Low Melatonin Levels Reported in T2DM Women With Reduced BMD
Clinical Model Stratifies OAB Risk in T2DM With High Accuracy Tags hBA1c Read more about Clinical Model Stratifies OAB Risk in T2DM With High Accuracy
Tirzepatide Shows Lower MCI Risk vs Semaglutide in T2DM Tags GLP-1 agonists Read more about Tirzepatide Shows Lower MCI Risk vs Semaglutide in T2DM
Combination Therapy Tied to Reduced Colon Cancer Risk in T2DM Tags GLP-1 agonists SGLT-2 Inhibitor Read more about Combination Therapy Tied to Reduced Colon Cancer Risk in T2DM
Low-Dose Colchicine Reduces MACE Risk in Diabetes Tags Myocardial infarction Stroke Read more about Low-Dose Colchicine Reduces MACE Risk in Diabetes